aTyr Pharma, Inc. (ATYR) — Cash Flow Reinvestment Rate
Latest as of March 2020:
0.08x
aTyr Pharma, Inc. (ATYR) has a Cash Flow Reinvestment Rate of 0.08x as of March 2020, reinvesting $166.00K (capex $166.00K ) from operating cash flow of $2.06 Million. Check ATYR cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.08x
(Capex + Investments) / Operating CF
Total Reinvested
$166.00K
Capex + Investments
Operating Cash Flow
$2.06 Million
USD
Capital Expenditures
$166.00K
USD
Annual Cash Flow Reinvestment Rate for aTyr Pharma, Inc. (None–None)
Year-by-year capital reinvestment analysis for aTyr Pharma, Inc.. For live market cap and broader valuation context, see aTyr Pharma, Inc. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow